Companies Dominating the Anti-Aging Drugs Landscape
- L’Oreal SA
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merz Pharma GmbH & Co.
- Novartis AG
- BioTime Inc.
- ARK Skincare
- Elysium Health Inc.
- Estee Lauder Inc.
- DermaFix
- Bayer Pharma AG
- La Roche-Posay
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of anti-aging drugs is assessed at USD 64.72 billion.
The anti-aging drugs market size was valued at USD 59.75 billion in 2024 and is anticipated to reach USD 215.95 billion by the end of 2037, expanding at around 10.3% CAGR during the forecast period i.e., between 2025-2037. Rising adoption of anti aging products, desire to look young and healthy among elderly people along with increasing disposable income will boost the market growth.
North America is projected to dominate majority industry share by 2037, driven by increasing number of non-invasive cosmetic treatments, the growing demand for anti-aging products, and rapid expansion of the personal care industry.
The major players in the market include L’Oreal SA, Merz Pharma GmbH & Co., Novartis AG, BioTime Inc., ARK Skincare, Elysium Health Inc., Estee Lauder Inc., DermaFix, Bayer Pharma AG, La Roche-Posay.
